Skip to main content
U.S. flag

An official website of the United States government

Return to Search

State Release 043

Guidance for : Several States have recently questioned whether Federal Financial Participation (FFP) dollars are available if a State chooses to cover experimental drugs. Experimental drugs include, for example, treatment investigational new drugs (INDs), group C cancer drugs and parallel track drugs.

Download the Guidance Document


Issued by: Centers for Medicare & Medicaid Services (CMS)

Issue Date: September 09, 1994

HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the

DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.